Tricuspid valve infective endocarditis in a non-IVDU patient with atopic dermatitis | Zendy

H Woodun | Zendy; Sarah Bouayyad | Zendy; Sura Sahib | Zendy; Nadir Elamin | Zendy; Steven Hunter | Zendy; Abdallah AlMohammad | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tricuspid valve infective endocarditis in a non-IVDU patient with atopic dermatitis

Author(s) -

H Woodun,

Sarah Bouayyad,

Sura Sahib,

Nadir Elamin,

Steven Hunter,

Abdallah AlMohammad

Publication year - 2020

Publication title -

oxford medical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.169

H-Index - 9

ISSN - 2053-8855

DOI - 10.1093/omcr/omaa045

Subject(s) - medicine , endocarditis , infective endocarditis , tricuspid valve , patent foramen ovale , atopic dermatitis , surgery , sepsis , flucloxacillin , transesophageal echocardiogram , clindamycin , staphylococcus aureus , cardiology , dermatology , antibiotics , percutaneous , biology , bacteria , microbiology and biotechnology , genetics

A 29-year-old male, with chronic atopic dermatitis (AD), presented with a 2-week history of fatigue, pyrexia and weight loss. Examination showed eczematous patches with lichenified papules, erosions on the right shin and a new murmur. Blood cultures isolated methicillin-sensitive Staphylococcus aureus. Transthoracic echocardiography showed vegetation on the tricuspid valve (TV) that was adherent to the septal leaflet. He was treated for infective endocarditis, attributed to poorly controlled AD, with intravenous Flucloxacillin. Due to ongoing sepsis and pulmonary septic emboli, Clindamycin was added. He underwent TV repair; the septal leaflet was excised, and the remnant two leaflets were brought together with a ring. His patent foramen ovale was closed. His skin was treated with topical steroids and emollients. Right-sided endocarditis of an intact TV is uncommon in a non-intravenous drug user. Therefore, this novel case portrays the importance of aggressively managing AD as it is a risk factor for significant systemic infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research